These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8102651)

  • 41. Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidine.
    Kavanaugh MP; Tester BC; Scherz MW; Keana JF; Weber E
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2844-8. PubMed ID: 2833756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroendocrinological and neurochemical effects of sigma ligands.
    Gudelsky GA; Nash JF
    Neuropharmacology; 1992 Feb; 31(2):157-62. PubMed ID: 1348112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor binding profiles of KB-5492, a novel anti-ulcer agent, at sigma receptors in guinea-pig brain.
    Harada Y; Hara H; Sukamoto T
    Eur J Pharmacol; 1994 May; 256(3):321-8. PubMed ID: 8045277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new approach to the design of sigma-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)ethylamine-related polyamines at sigma-1 and sigma-2 receptor subtypes.
    de Costa BR; He XS; Dominguez C; Cutts J; Williams W; Bowen WD
    J Med Chem; 1994 Jan; 37(2):314-21. PubMed ID: 8295220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel phenylaminotetralin radioligand reveals a subpopulation of histamine H(1) receptors.
    Booth RG; Moniri NH; Bakker RA; Choksi NY; Nix WB; Timmerman H; Leurs R
    J Pharmacol Exp Ther; 2002 Jul; 302(1):328-36. PubMed ID: 12065734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
    Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
    J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (E)-8-benzylidene derivatives of 2-methyl-5-(3-hydroxyphenyl)morphans: highly selective ligands for the sigma 2 receptor subtype.
    Bertha CM; Vilner BJ; Mattson MV; Bowen WD; Becketts K; Xu H; Rothman RB; Flippen-Anderson JL; Rice KC
    J Med Chem; 1995 Nov; 38(24):4776-85. PubMed ID: 7490727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY
    Eur J Pharmacol; 1992 Dec; 227(4):371-8. PubMed ID: 1359973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release.
    Liu X; Nuwayhid S; Christie MJ; Kassiou M; Werling LL
    Eur J Pharmacol; 2001 Jun; 422(1-3):39-45. PubMed ID: 11430911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity.
    Hacksell U; Svensson U; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Lindenberg P; Sanchez D
    J Med Chem; 1979 Dec; 22(12):1469-75. PubMed ID: 317109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
    Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
    Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction.
    Ogawa S; Okuyama S; Araki H; Otomo S
    Eur J Pharmacol; 1994 Sep; 263(1-2):9-15. PubMed ID: 7821367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediam ines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes.
    de Costa BR; Dominguez C; He XS; Williams W; Radesca L; Bowen W
    J Med Chem; 1992 Nov; 35(23):4334-43. PubMed ID: 1447735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase.
    Moebius FF; Reiter RJ; Hanner M; Glossmann H
    Br J Pharmacol; 1997 May; 121(1):1-6. PubMed ID: 9146879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
    Weber E; Sonders M; Quarum M; McLean S; Pou S; Keana JF
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8784-8. PubMed ID: 2877462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
    Horn AS; Kaptein B; Mulder TB; de Vries JB; Wynberg H
    J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.
    Liu Y; Yu H; Mohell N; Nordvall G; Lewander T; Hacksell U
    J Med Chem; 1995 Jan; 38(1):150-60. PubMed ID: 7530773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.